Long‐term comparative safety analysis of the risks associated with adding or switching to a sulfonylurea as second‐line Type 2 diabetes mellitus treatment in a US veteran population
Sign Up to like & getrecommendations! Published in 2018 at "Diabetic Medicine"
DOI: 10.1111/dme.13839
Abstract: To examine the risks of all‐cause mortality and cardiovascular events associated with adding vs switching to second‐line therapies in a comparative safety study of people with Type 2 diabetes mellitus. read more here.
Keywords: associated adding; type diabetes; diabetes mellitus; adding switching ... See more keywords